Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Esflurbiprofen
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Phase III
Sponsor : Clinsearch GmbH | CRM Biometrics | SocraTec R&D GmbH | SocraMetrics GmbH | HWI Pharma Services
Deal Size : Inapplicable
Deal Type : Inapplicable
Phase III Trial to Assess the Safety and Efficacy of TK-254RX in Patients With Contusions
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 11, 2025
Lead Product(s) : Esflurbiprofen
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Phase III
Sponsor : Clinsearch GmbH | CRM Biometrics | SocraTec R&D GmbH | SocraMetrics GmbH | HWI Pharma Services
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Esflurbiprofen
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : SocraTec R&D GmbH | SocraMetrics GmbH | HWI Pharma Services
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 11, 2025
Lead Product(s) : Esflurbiprofen
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : SocraTec R&D GmbH | SocraMetrics GmbH | HWI Pharma Services
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Esflurbiprofen
Therapeutic Area : Orthopedics/Orthopedic Surgery
Study Phase : Phase III
Sponsor : CRM Biometrics | SocraTec R&D GmbH | SocraMetrics GmbH | HWI Pharma Services | Clinsearch GmbH
Deal Size : Inapplicable
Deal Type : Inapplicable
Phase III Trial to Evaluate the Efficacy and Safety in Patients With Ankle Sprains.
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 10, 2025
Lead Product(s) : Esflurbiprofen
Therapeutic Area : Orthopedics/Orthopedic Surgery
Highest Development Status : Phase III
Sponsor : CRM Biometrics | SocraTec R&D GmbH | SocraMetrics GmbH | HWI Pharma Services | Clinsearch GmbH
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Esflurbiprofen
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : SocraTec R&D GmbH | SocraMetrics GmbH | HWI Pharma Services
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 12, 2025
Lead Product(s) : Esflurbiprofen
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : SocraTec R&D GmbH | SocraMetrics GmbH | HWI Pharma Services
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : TK-254RX
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : ClinSearch | SocraTec R&D GmbH | SocraMetrics GmbH | CRM Biometrics | Clinigen Clinical Supplies Management
Deal Size : Inapplicable
Deal Type : Inapplicable
Open Label Trial to Evaluate the Adhesion of TK-254RX in Healthy Volunteers.
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
September 18, 2023
Lead Product(s) : TK-254RX
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : ClinSearch | SocraTec R&D GmbH | SocraMetrics GmbH | CRM Biometrics | Clinigen Clinical Supplies Management
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Esflurbiprofen
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Phase II
Sponsor : ClinSearch | CRM Biometrics | Clinigen Group
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy and Safety of Esflurbiprofen Hydrogel Patch in the Treatment of Local Acute Pain
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 01, 2021
Lead Product(s) : Esflurbiprofen
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Phase II
Sponsor : ClinSearch | CRM Biometrics | Clinigen Group
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Esflurbiprofen
Therapeutic Area : Orthopedics/Orthopedic Surgery
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Proof-of-concept Study of NSAID Hydrogel Patch in Treatment of Acute Pain
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 06, 2016
Lead Product(s) : Esflurbiprofen
Therapeutic Area : Orthopedics/Orthopedic Surgery
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable